Awaiting FDA nod, Novartis touts latest data on gene therapy Zolgensma
Novartis' AveXis presented its latest interim Zolgensma data at the AAN annual meeting in Philadelphia on Sunday. (Pixabay)
As Novartis waits for FDA action on i...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.